Project Number 1UG1EY033286-01 Agency/Funding Organization NEI Funding Year 2022 View Full Project Details for NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
